Management of Yeast in Urine
Most patients with yeast in their urine do not require antifungal treatment, as candiduria typically represents benign colonization rather than infection. 1
Initial Assessment: Determine If Treatment Is Needed
The presence of yeast in urine must be evaluated based on symptoms and risk factors, not simply treated reflexively. 1
Asymptomatic Candiduria (No Treatment Required)
For patients without symptoms or high-risk features:
- Observation alone is appropriate for asymptomatic candiduria in most patients, including those with diabetes mellitus or mild immunosuppression. 1, 2
- Remove predisposing factors such as indwelling urinary catheters (clears candiduria in ~50% of cases) and discontinue unnecessary broad-spectrum antibiotics. 1, 2
- Candiduria progresses to candidemia in less than 5% of cases and treatment does not reduce mortality. 2
High-Risk Patients Requiring Treatment Despite Being Asymptomatic
Treatment is mandatory for asymptomatic candiduria in these specific populations:
- Neutropenic patients with persistent unexplained fever and candiduria 1, 2
- Very low birth weight neonates (at high risk for disseminated candidiasis) 1, 2
- Patients undergoing urologic procedures or instrumentation (high risk for candidemia) 1, 3
- Severely immunocompromised patients with fever and urinary tract obstruction 4, 2
For these high-risk patients undergoing urologic procedures: fluconazole 200-400 mg (3-6 mg/kg) daily or amphotericin B deoxycholate 0.3-0.6 mg/kg daily for several days before and after the procedure. 1, 3
Treatment Algorithm for Symptomatic Candiduria
Symptomatic Cystitis (Urinary Frequency, Dysuria, Suprapubic Pain)
First-line treatment: Fluconazole 200 mg (3 mg/kg) orally daily for 2 weeks for fluconazole-susceptible Candida species (C. albicans, C. tropicalis, C. parapsilosis). 1, 4, 3
- Fluconazole achieves high urinary concentrations in active form, making it superior to all other antifungals for lower urinary tract infections. 4, 3
- C. albicans is typically fluconazole-susceptible, while C. glabrata and C. krusei are often resistant. 4
For fluconazole-resistant species (C. glabrata, C. krusei):
- Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1, 4
- Oral flucytosine 25 mg/kg four times daily for 7-10 days (alternative option) 1, 4
Candida Pyelonephritis (Fever, Flank Pain, Systemic Symptoms)
First-line treatment: Fluconazole 200-400 mg (3-6 mg/kg) orally daily for 2 weeks for fluconazole-susceptible organisms. 1, 3
For fluconazole-resistant C. glabrata:
- Amphotericin B deoxycholate 0.5-0.7 mg/kg daily with or without flucytosine 25 mg/kg four times daily for 2 weeks 1
- Flucytosine alone at 25 mg/kg four times daily for 2 weeks is an alternative. 1
Fungus Balls (Obstructing Masses in Renal Collecting System)
- Surgical or endoscopic removal is mandatory in non-neonates. 1, 3
- Adjunctive systemic therapy: Fluconazole 200-400 mg (3-6 mg/kg) daily 1
- Alternative: Amphotericin B deoxycholate 0.5-0.7 mg/kg daily with or without flucytosine 25 mg/kg four times daily 1
- If access to renal collecting system is available, irrigation with amphotericin B 50 mg/L of sterile water can be used as adjunct. 1
- Continue treatment until symptoms resolve and urine cultures are negative for Candida. 1
Suspected Disseminated Candidiasis with Candiduria
- Treat as candidemia with systemic antifungal therapy (not limited to urinary-specific agents). 1
- Consider imaging (ultrasound or CT) to rule out structural abnormalities, hydronephrosis, or fungus ball formation. 4
Critical Pitfalls to Avoid
Do NOT Use These Agents for Candida UTI:
- Echinocandins (caspofungin, micafungin, anidulafungin) achieve minimal urinary concentrations and are ineffective for lower urinary tract infections. 4, 3
- Lipid formulations of amphotericin B do not achieve adequate urine concentrations. 4
- Voriconazole and other azoles (besides fluconazole) have minimal urinary excretion. 4, 3
Do NOT Treat:
- Asymptomatic candiduria in otherwise healthy patients (including those with diabetes alone or advanced age alone). 1, 2
- Treatment of asymptomatic candiduria does not prevent complications or reduce mortality. 2
Do NOT Overlook:
- Possibility of disseminated candidiasis in high-risk patients (neutropenic, neonates, severely immunocompromised). 4, 2
- Need for catheter removal as a primary intervention before considering antifungal therapy. 2